ORBIMED ADVISORS LLC 13D/13G Filings for CTI BioPharma Corp. (CTIC)

ORBIMED ADVISORS LLC 13D and 13G filings for CTI BioPharma Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-12-06
4:25 pm
Sale
2021-12-02 13G CTI BioPharma Corp.
CTIC
ORBIMED ADVISORS LLC 4,024,821
4.000%
-5,495,179decrease
(-57.72%)
Filing